Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hans E. Junginger is active.

Publication


Featured researches published by Hans E. Junginger.


Journal of Controlled Release | 1998

Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2)

A.F Kotzé; H.L. Lueßen; Bas J. de Leeuw; Bert G de Boer; J. Coos Verhoef; Hans E. Junginger

A partially quaternized chitosan derivative, N-trimethyl chitosan chloride (TMC) (degree of quaternization 12.28%), was synthesized and the effects of this novel polymer on the permeability of intestinal epithelial cells, using Caco-2 cell monolayers, were investigated and compared with those of chitosan hydrochloride and chitosan glutamate. Transepithelial electrical resistance (TEER) measurements at pH 6.20 revealed that all these polymers (0.25-1.5% w/v) caused an immediate and pronounced lowering in TEER values in the order chitosan hydrochloride (84% reduction after 2 h incubation) > chitosan glutamate (60% reduction) > TMC (24% reduction) at 0.25% w/v concentrations. At higher concentrations (up to 2.5% w/v), TMC was able to decrease the TEER further. Similar results were obtained in transport studies, using the hydrophilic radioactive markers, [14C]-mannitol (MW 182.2) and [14C]-polyethylene glycol 4000 (PEG-4000, MW 4000). Large increases in the permeation of these markers were found. The transport of [14C]-mannitol was increased 34-fold (chitosan hydrochloride), 25-fold (chitosan glutamate) and 11-fold (TMC) at 0.25% w/v concentrations. Further increases in the permeation of both markers were found at higher concentrations of TMC. Due to its quaternary structure, TMC is better soluble than the other chitosan salts, and its higher solubility may compensate for its lesser effectivity at similar concentrations. It is also soluble at pH 7.40, where the chitosan salts are insoluble and therefore ineffective. No deleterious effects to the cells could be demonstrated with trypan blue exclusion studies and confocal laser scanning microscopy (CLSM). CLSM confirmed that these polymers increase the transport of large hydrophilic compounds (using the fluorescent markers FD-4, MW 4400 and FD-20, MW 19,600) through opening of tight junctions to allow for paracellular transport. It is concluded from this study that the charge, charge density and the structural features of chitosans and chitosan derivatives are important factors determining their potential use as absorption enhancers.


Vaccine | 2003

Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice.

Inez M. van der Lubben; Gideon Kersten; Marjan M. Fretz; Coen Beuvery; J. Coos Verhoef; Hans E. Junginger

In this study, the ability of chitosan microparticles to enhance both the systemic and local immune responses against diphtheria toxoid (DT) after oral and nasal administration in mice was investigated.Firstly, DT was associated to chitosan microparticles to determine antigen loading and release. Then DT loaded chitosan microparticles, DT in phosphate buffered saline (PBS) and empty chitosan microparticles (as controls) were fed intragastrically and administered nasally to mice. Mice were also subcutaneously immunised with DT associated with alum. All mice were vaccinated in week 1 and boosted in week 3. Sera were analysed for anti-DT IgG and nasal washings and faeces for anti-DT IgA titres using an enzyme linked immunosorbent assay. Loading capacities of about 25% and loading efficacies of about 100% were obtained after loading the chitosan microparticles with DT. No DT was released at 37 degrees C in PBS. Compared to intragastrical feeding with DT in PBS, a strong enhancement of the systemic and local immune responses against DT were found in mice fed with DT loaded chitosan microparticles. In addition, a dose-dependent immune reaction was observed for mice vaccinated with different doses of DT associated to chitosan microparticles. Significant systemic humoral immune responses were also found after nasal vaccination with DT associated to chitosan microparticles.DT associated to chitosan microparticles results in protective systemic and local immune response against DT after oral vaccination, and in significant enhancement of IgG production after nasal administration. Hence, these in vivo experiments demonstrate that chitosan microparticles are very promising mucosal vaccine delivery systems.


European Journal of Pharmaceutical Sciences | 1999

Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.

A.F Kotzé; H.L. Lueßen; A.G. de Boer; J.C. Verhoef; Hans E. Junginger

In this study the effects of two chitosan salts, namely chitosan hydrochloride and chitosan glutamate (0.5 and 1.5% w/v), on the transepithelial electrical resistance (TEER) and permeability of Caco-2 cell monolayers, using the radioactive marker [14C]-mannitol, were investigated in a slightly acidic (pH 6.2) and neutral (pH 7.4) environment. Both salts are soluble in acidic conditions up to a concentration of 1.5% w/v and solutions of this strength, at a pH of 6.2, caused a pronounced lowering in the TEER of Caco-2 cell monolayers in the order of 70+/-1% (chitosan glutamate) and 77+/-3% (chitosan hydrochloride), 20 min after incubation started. In agreement with the TEER results the transport of the radioactive marker, [14C]-mannitol, was increased 25-fold (chitosan glutamate) and 36-fold (chitosan hydrochloride), respectively, at this pH. However, at a pH of 7.4 both salts are insoluble and prove to be ineffective since no reduction in the TEER values or increase in the transport of [14C]-mannitol were found. The results show that these chitosan salts are potent absorption enhancers in acidic environments. We conclude that there is a need for chitosan derivatives with increased solubility, especially at neutral and basic pH values, for use as absorption enhancers aimed at the delivery of therapeutic compounds in the more basic environment of the large intestine and colon.


Pharmaceutical Science & Technology Today | 1998

Macromolecules as safe penetration enhancers for hydrophilic drugs—a fiction?

Hans E. Junginger; J. Coos Verhoef

Abstract The early designs of a variety of low molecular weight transmucosal penetration enhancers for improved absorption of hydrophilic drugs (e.g. peptides and proteins) hampered their commercialization, primarily because of related mechanisms of action and inherent toxicities. During the past decade, however, novel types of macromolecular penetration enhancers, such as anionic polyacrylates and cationic chitosan and chitosan derivatives, have been developed. These polymers can enhance the paracellular permeability of mucosal epithelia (intestinal, nasal) by transiently opening the tight junctions, thereby increasing the paracellular absorption of hydrophilic and macromolecular drugs. Neither of these two classes of polymers interact with mucosal cell membrane components and consequently do not enhance transcellular transport of hydrophilic compounds. The polyacrylates and chitosan derivatives show no acute toxicity and are not absorbed. These characteristics favour the conclusion that both types of polymers are safe penetration enhancers for transmucosal delivery of hydrophilic drugs and offer promising prospects for novel pharmaceutical applications.


European Journal of Pharmaceutical Sciences | 2002

Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin.

Farid Abedin Dorkoosh; J. Coos Verhoef; Matheus H.C. Ambagts; Morteza Rafiee-Tehrani; Gerrit Borchard; Hans E. Junginger

Novel peroral peptide drug delivery systems based on superporous hydrogel (SPH) and SPH composite (SPHC) have recently been developed in our laboratory. In this report the following issues were studied: release of the peptide drugs buserelin, octreotide and insulin from SPH and SPHC polymers and the developed delivery systems, stability of these peptides during the release and the integrity of insulin in the polymeric matrix of SPHC. Release studies from SPH and SPHC polymers revealed that buserelin, octreotide and insulin were released almost completely from the polymers. Peptide release rates from SPH were faster than from SPHC, due to the more porous structure of SPH polymer. All peptides studied in contact with SPHC polymer were stable under different environmental conditions (ambient temperature, 37 degrees C, light and darkness and at pH values 3.2 and 7.2). FTIR studies demonstrated that no covalent binding occurred between insulin and the polymeric SPHC matrix. Release profiles of all peptides from the developed delivery systems showed a time-controlled release profile: after a short lag time of 10-15 min, a burst release of peptides occurred during which more than 80% of peptide was released within 30-45 min. In conclusion, the present delivery systems based on SPH and SPHC show appropriate in vitro properties for application in peroral peptide drug delivery of buserelin, octreotide and insulin, and are therefore promising for further in vivo evaluation.


International Journal of Pharmaceutics | 2002

Effects of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cell monolayers

Farid Abedin Dorkoosh; Dewi Setyaningsih; Gerrit Borchard; Morteza Rafiee-Tehrani; J. Coos Verhoef; Hans E. Junginger

The aim of this study was to evaluate the effect of superporous hydrogel (SPH) and SPH composite (SPHC) as permeation enhancers for peptide drug delivery on Caco-2 cell monolayers. Moreover, the cytotoxic effects of these polymers were also studied using trypan blue test, MTT assay and propidium iodide staining. Transepithelial electrical resistance (TEER) studies revealed that both SPH and SPHC polymers were able to decrease TEER values to about 40% of initial values, indicating the ability of these polymers to open tight junctions. Recovery studies of TEER showed that the effects of polymers on Caco-2 cell monolayers were reversible, indicating viability of the cells after incubation with polymers. Both polymers were able to enhance the transport of the hydrophilic marker 14C-mannitol up to 2.7 and 3.8-fold in comparison to the control group. The cumulative transport of fluorescein isothiocyanate labelled dextrans with a molecular weight of 4400 Da (FD4) and 19600 Da (FD20) was enhanced by SPH and SPHC polymers by opening of tight junctions; however, this enhancement was inversely proportional to the molecular weight of marker compounds. Cytotoxicity studies confirmed that the transport enhancing properties of SPH and SPHC polymers were not caused by damage of the Caco-2 cell monolayers. The cells were able to exclude trypan blue as well as propidium iodide after incubation with SPH and SPHC polymers. MTT assay showed that the number of viable cells was higher than 95% after incubation with SPH and SPHC polymers. This indicates that the mitochondrial metabolic activities of the cells were preserved after application of the polymers.


European Journal of Pharmaceutics and Biopharmaceutics | 2004

Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs

S.M. van der Merwe; J.C. Verhoef; J.H.M. Verheijden; A.F. Kotzé; Hans E. Junginger


Vaccine | 2007

N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model

Maryam Amidi; Stefan Romeijn; J. Coos Verhoef; Hans E. Junginger; Laura Bungener; Anke Huckriede; Daan J.A. Crommelin; Wim Jiskoot


International Journal of Pharmaceutics | 2002

Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state.

V.H.M Deneer; G.B Drese; P.E.H Roemelé; J.C. Verhoef; L Lie-A-Huen; J.H Kingma; J.R.B.J Brouwers; Hans E. Junginger


Drugs and the pharmaceutical sciences | 1999

MULTIFUNCTIONAL POLYMERS FOR THE PERORAL DELIVERY OF PEPTIDE DRUGS

Henrik L. Luessen; J. Coos Verhoef; A.G. de Boer; Hans E. Junginger; B.J. de Leeuw; Gerrit Borchard; C.-M. Lehr

Collaboration


Dive into the Hans E. Junginger's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A.F Kotzé

Potchefstroom University for Christian Higher Education

View shared research outputs
Top Co-Authors

Avatar

Anke Huckriede

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge